Literature DB >> 24802850

Astragaloside IV inhibits the up-regulation of Wnt/β-catenin signaling in rats with unilateral ureteral obstruction.

Li Wang1, Yang-Feng Chi, Ze-Ting Yuan, Wen-Chao Zhou, Pei-Hao Yin, Xue-Mei Zhang, Wen Peng.   

Abstract

OBJECTIVE: To investigate the effect of Astragaloside IV (AS-IV) on the regulation of the Wnt/β-catenin signaling pathway in rats with unilateral ureteral obstruction (UUO).
METHODS: Rat renal interstitial fibrosis models were prepared using unilateral ureteral ligation. Rats were randomly divided into sham group, sham group with AS-IV (33mg/kg), unilateral ureteral obstruction group, and unilateral ureteral obstruction group receiving varied doses of AS-IV (3.3, 10, and 33 mg/kg). Immunohistochemical analysis, real-time fluorescence quantitative PCR (FQ-PCR), and western blot were used to detect the expression of genes and proteins associated with the Wnt/β-catenin signaling pathway in renal tissues.
RESULTS: Levels of Wnt3, Wnt4, and Frizzled gene expression increased significantly in the UUO model; AS-IV was associated with the downregulation of the expression of Wnt3, Wnt4, Frizzled4, p-LRP5, p-LRP6, disheveled, β-catenin, LEF-1, TCF-1, Snail, Jagged 1, Twist, MMP2, and MMP7 proteins in a concentration-dependent manner, while the expression of APC, CK1, and E-cadherin was increased.
CONCLUSIONS: AS-IV effectively inhibits the up-regulation of proteins in the Wnt/β-catenin signaling pathway in UUO-model rats, indicating its possible inhibitory effects on renal interstitial fibrosis.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24802850     DOI: 10.1159/000358699

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.

Authors:  Yongsheng Jiang; Qinghua Meng; Jiaqin Qi; Haiyu Shen; Shaochuan Sun
Journal:  Tumour Biol       Date:  2015-04-30

Review 2.  Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis.

Authors:  Xiao-Yuan Liu; Xu-Bin Zhang; Ya-Feng Zhao; Kai Qu; Xiao-Yong Yu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

3.  β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.

Authors:  Catherina A Cuevas; Cheril Tapia-Rojas; Carlos Cespedes; Nibaldo C Inestrosa; Carlos P Vio
Journal:  Biomed Res Int       Date:  2015-04-07       Impact factor: 3.411

4.  Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy.

Authors:  Hengjiang Guo; Aili Cao; Shuang Chu; Yi Wang; Yingjun Zang; Xiaodong Mao; Hao Wang; Yunman Wang; Cheng Liu; Xuemei Zhang; Wen Peng
Journal:  Front Pharmacol       Date:  2016-12-21       Impact factor: 5.810

5.  Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.

Authors:  Xiaolei Wang; Yanbin Gao; Nianxiu Tian; Dawei Zou; Yimin Shi; Nan Zhang
Journal:  Drug Des Devel Ther       Date:  2018-08-06       Impact factor: 4.162

6.  A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.

Authors:  Xuemin He; Rui Cheng; Chao Huang; Yusuke Takahashi; Yanhui Yang; Siribhinya Benyajati; Yanming Chen; Xin A Zhang; Jian-Xing Ma
Journal:  Signal Transduct Target Ther       Date:  2020-04-29

7.  Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway.

Authors:  ZhongYu Jiang; Zhen Mao
Journal:  RSC Adv       Date:  2019-11-01       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.